ciprofloxacin vs infliximab
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of ciprofloxacin and infliximab. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
Serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of CD including corticosteroids, antibiotics (metronidazole or ciprofloxacin) and aminosalicylates.
Cipro
Remicade
Ciprofloxacin eye drops are an antibiotic medicine. They treat bacterial infections in the eye.
Inflectra is a medicine that blocks a protein called TNF. It is used to treat autoimmune diseases and reduce inflammation.
These eye drops treat corneal ulcers and conjunctivitis (pink eye) caused by certain bacteria. Corneal ulcers are open sores on the eye. Conjunctivitis is an infection that makes the eye red and swollen.
Inflectra treats Crohn's disease in adults and children (6+). It helps reduce symptoms and keep the disease under control. It also treats ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.
Ciprofloxacin is a fluoroquinolone antibiotic. It stops bacteria from growing and multiplying. This helps your body fight off the infection.
Inflectra blocks a protein in your body called tumor necrosis factor (TNF). TNF can cause inflammation and damage in autoimmune diseases. By blocking TNF, Inflectra can reduce inflammation and improve symptoms.
- • Burning or discomfort in the eye
- • White crystal-like build-up in the eye
- • Infections (like colds, sinus infections, and sore throat)
- • Infusion-related reactions
- • Headache
- • Abdominal pain
- Drug Hypersensitivity 5,673
- Pain 5,587
- Fatigue 5,503
- Diarrhoea 5,326
- Nausea 5,298
- Infusion Related Reaction 18,648
- Condition Aggravated 18,301
- Rheumatoid Arthritis 18,136
- Pain 18,107
- Arthralgia 16,853
Do not inject this medicine into your eye. Some people have had very bad allergic reactions, even after the first dose. Get emergency help right away if you have trouble breathing, pass out, or have swelling of the face, throat, or tongue.
Inflectra can increase your risk of serious infections that may lead to hospitalization or death. Tell your doctor if you have any infection symptoms. You should be tested for tuberculosis (TB) before starting Inflectra. Some people, especially children and young adults, have developed cancers like lymphoma while taking TNF blockers. Some of these cancers have been fatal.
Tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. It is not known if ciprofloxacin eye drops will harm an unborn baby. It is also not known if ciprofloxacin passes into breast milk.
Tell your doctor if you are pregnant or plan to become pregnant. Inflectra can pass to your baby during pregnancy, mainly in the third trimester. Live vaccines are not recommended for at least 6 months after birth for babies exposed to Inflectra in the womb.
Also Compare, Nearby Drugs
Compare ciprofloxacin with
Compare infliximab with
How to Read This ciprofloxacin vs infliximab Comparison
ciprofloxacin is classified in the Fluoroquinolone Antibiotic drug class, while infliximab sits within the TNF-Alpha Inhibitor (Biologic) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, ciprofloxacin has 27,387 submissions while infliximab has 90,045. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to this antibiotic does not appear to change the amount of infliximab that stays in your blood.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for ciprofloxacin or infliximab.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.